Religare Enterprises Earnings Call Transcript: Key Takeaways
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.
Religare Q1FY27 shows strategic focus on core segments. Consolidated revenue grew 26% YoY to ₹2,358 Cr, though PAT remains negative at ₹46.9 Cr due to reporting standard transitions and investment modes.
Religare reported Q1 FY27 consolidated revenue of Rs. 2,358.4 Cr, up 26% YoY, driven by strong performance in the Insurance segment. Net profit turned into a loss of Rs. 46.9 Cr.
Religare Enterprises reported FY26 consolidated total income of ₹8,493cr and PAT of ₹73.16cr. Management is restructuring via demerger into two listed entities: Health Insurance and Financial Services.